Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Impact of sample processing on the measurement of circulating microparticles: storage and centrifugation parameters.

Vila-Liante V, Sánchez-López V, Martínez-Sales V, Ramón-Nuñez LA, Arellano-Orden E, Cano-Ruiz A, Rodríguez-Martorell FJ, Gao L, Otero-Candelera R.

Clin Chem Lab Med. 2016 Nov 1;54(11):1759-1767. doi: 10.1515/cclm-2016-0036.

PMID:
27155005
2.

Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma.

Reynés G, Martínez-Sales V, Vila V, Balañá C, Pérez-Segura P, Vaz MA, Benavides M, Gallego O, Palomero I, Gil-Gil M, Fleitas T, Reche E.

Anticancer Drugs. 2016 Feb;27(2):133-7. doi: 10.1097/CAD.0000000000000314.

PMID:
26574999
3.

High correlation between 2 flow cytometry platforms in the microparticles analysis using a new calibrated beads strategy.

Sánchez-López V, Vila-Liante V, Arellano-Orden E, Elías-Hernández T, Ramón-Nuñez LA, Jara-Palomares L, Martínez-Sales V, Gao L, Otero-Candelera R.

Transl Res. 2015 Dec;166(6):733-9. doi: 10.1016/j.trsl.2015.08.006. Epub 2015 Aug 20.

PMID:
26342453
4.

Increased circulating endothelial cells and microparticles in patients with psoriasis.

Martínez-Sales V, Vila V, Ricart JM, Vayá A, Todolí J, Nńñez C, Contreras T, Ballester C, Reganon E.

Clin Hemorheol Microcirc. 2015;60(3):283-90. doi: 10.3233/CH-131766.

PMID:
24002122
5.

Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value.

Reynés G, Vila V, Fleitas T, Reganon E, Font de Mora J, Jordá M, Martínez-Sales V.

PLoS One. 2013 Jul 29;8(7):e69034. doi: 10.1371/journal.pone.0069034. Print 2013.

6.

Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk.

Navarro S, Medina P, Bonet E, Corral J, Martínez-Sales V, Martos L, Rivera M, Roselló-Lletí E, Alberca I, Roldán V, Mira Y, Ferrando F, Estellés A, Vicente V, Bertina RM, España F.

Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1435-40. doi: 10.1161/ATVBAHA.113.301360. Epub 2013 Mar 21.

PMID:
23520161
7.

VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.

Fleitas T, Martínez-Sales V, Vila V, Reganon E, Mesado D, Martín M, Gómez-Codina J, Montalar J, Reynés G.

Clin Transl Oncol. 2013 Nov;15(11):897-902. doi: 10.1007/s12094-013-1020-6. Epub 2013 Mar 5.

PMID:
23463593
8.

Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer.

Fleitas T, Martínez-Sales V, Vila V, Reganon E, Mesado D, Martín M, Gómez-Codina J, Montalar J, Reynés G.

PLoS One. 2012;7(10):e47365. doi: 10.1371/journal.pone.0047365. Epub 2012 Oct 15.

9.

Are there differences in acute phase inflammation markers regarding the type of heart failure?

Sánchez-Lázaro IJ, Almenar-Bonet L, Reganon-Salvador E, Vila-Liante V, Martínez-Sales V, Martínez-Dolz L, Agüero-Ramón-Llin J, Salvador-Sanz A.

Heart Int. 2011;6(2):e17. doi: 10.4081/hi.2011.e17. Epub 2011 Oct 21.

10.

Circulating endothelial cells in patients with heart failure and left ventricular dysfunction.

Martínez-Sales V, Sánchez-Lázaro I, Vila V, Almenar L, Contreras T, Reganon E.

Dis Markers. 2011;31(2):75-82. doi: 10.3233/DMA-2011-0801.

11.

Atorvastatin neutralises the thrombin-induced tissue factor expresion in endothelial cells via geranylgeranyl pyrophosphate.

Martínez-Sales V, Vila V, Ferrando M, Reganon E.

Cytotechnology. 2011 Jan;63(1):1-5. doi: 10.1007/s10616-010-9319-4. Epub 2010 Nov 4.

12.

[Circulating endothelial cells and microparticles in patients with antiphospholipid antibodies].

Martínez-Sales V, Vila V, Micó L, Contreras MT, Escandell A, Reganon E.

Med Clin (Barc). 2011 Apr 16;136(10):431-3. doi: 10.1016/j.medcli.2010.06.020. Epub 2010 Nov 3. Spanish.

PMID:
21051055
13.

Circulating endothelial and endothelial progenitor cells in non-small-cell lung cancer.

Fleitas T, Martínez-Sales V, Gómez-Codina J, Martín M, Reynés G.

Clin Transl Oncol. 2010 Aug;12(8):521-5. doi: 10.1007/s12094-010-0549-x. Review.

PMID:
20709649
14.

Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma.

Reynés G, Vila V, Martín M, Parada A, Fleitas T, Reganon E, Martínez-Sales V.

J Neurooncol. 2011 Mar;102(1):35-41. doi: 10.1007/s11060-010-0290-x. Epub 2010 Jul 6.

PMID:
20607353
15.

What is the best biomarker for diagnosis of rejection in heart transplantation?

Martínez-Dolz L, Almenar L, Reganon E, Vila V, Sánchez-Soriano R, Martínez-Sales V, Moro J, Agüero J, Sánchez-Lázaro I, Salvador A.

Clin Transplant. 2009 Sep-Oct;23(5):672-80. doi: 10.1111/j.1399-0012.2009.01074.x. Epub 2009 Aug 27.

PMID:
19712083
16.

Erythrocyte membrane composition in patients with primary hypercholesterolemia.

Vayá A, Martínez Triguero M, Réganon E, Vila V, Martínez Sales V, Solá E, Hernández Mijares A, Ricart A.

Clin Hemorheol Microcirc. 2008;40(4):289-94. Erratum in: Clin Hemorheol Microcirc. 2009;41(2):149. Ricart, A [added].

PMID:
19126991
17.

Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.

Martínez-Dolz L, Almenar L, Reganon E, Vila V, Chamorro C, Andrés L, Martínez-Sales V, Moro J, Agüero J, Sánchez-Lázaro I, Salvador A.

J Heart Lung Transplant. 2008 Jul;27(7):760-6. doi: 10.1016/j.healun.2008.04.010. Epub 2008 Jun 6.

PMID:
18582806
18.

Inflammatory markers in stable heart failure and their relationship with functional class.

Sánchez-Lázaro IJ, Almenar L, Reganon E, Vila V, Martínez-Dolz L, Martínez-Sales V, Moro J, Agüero J, Ortiz-Martínez V, Salvador A.

Int J Cardiol. 2008 Oct 13;129(3):388-93. Epub 2007 Nov 26. Erratum in: Int J Cardiol. 2011 Feb 3;146(3):484.

PMID:
18022711
19.

Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells.

Martínez-Sales V, Vila V, Ferrando M, Reganon E.

Endothelium. 2007 Jul-Oct;14(4-5):233-8.

PMID:
17922340
20.

Inflammation, endothelial dysfunction and angiogenesis markers in chronic heart failure patients.

Vila V, Martínez-Sales V, Almenar L, Lázaro IS, Villa P, Reganon E.

Int J Cardiol. 2008 Nov 12;130(2):276-7. Epub 2007 Aug 28. Erratum in: Int J Cardiol. 2011 Feb 3;146(3):484.

PMID:
17727986
21.

Erythrocyte deformability in obesity measured by ektacytometric techniques.

Solá E, Vayá A, Santaolaria ML, Hernández-Mijares A, Réganon E, Vila V, Martínez-Sales V, Corella D.

Clin Hemorheol Microcirc. 2007;37(3):219-27.

PMID:
17726251
22.

Diagnostic usefulness of inflammatory markers in acute cellular rejection after heart transplantation.

Sánchez-Soriano RM, Almenar L, Martínez-Dolz L, Reganon E, Martínez-Sales V, Chamorro CI, Vila V, Martín-Pastor J, Villa P, Salvador A.

Transplant Proc. 2006 Oct;38(8):2569-71.

PMID:
17098005
23.

Usefulness of von Willebrand factor in cardiac allograft vasculopathy: preliminary experience.

Chamorro CI, Almenar L, Martínez-Dolz L, Reganon E, Sánchez-Lacuesta E, Villa P, Ten F, Andrés L, Martínez-Sales V, Salvador A.

Transplant Proc. 2006 Oct;38(8):2566-8.

PMID:
17098004
24.

Regulation of cytosolic PlA2 activity by PP1/PP2A serine/threonine phosphatases in human platelets.

Moscardó A, Vallés J, Piñón M, Aznar J, Martínez-Sales V, Santos MT.

Platelets. 2006 Sep;17(6):405-15.

PMID:
16973502
25.

Sialic acid is an inflammation marker associated with a history of deep vein thrombosis.

Reganon E, Vila V, Martínez-Sales V, Vayá A, Mira Y, Ferrando F, Aznar J.

Thromb Res. 2007;119(1):73-8. Epub 2006 Feb 28.

PMID:
16500696
26.

Erythrocyte aggregation and -455G/A polymorphism of the beta-fibrinogen gene in survivors of acute myocardial infarction.

Vayá A, Breña S, Réganon E, Vila V, Martinez-Sales V, Contreras MT, Zorio E, Corella D, Aznar J.

Thromb Haemost. 2004 Jul;92(1):223-4. No abstract available.

PMID:
15213870
27.

Association between inflammation and hemostatic markers in atherothrombotic stroke.

Reganon E, Vila V, Martínez-Sales V, Vaya A, Lago A, Alonso P, Aznar J.

Thromb Res. 2003;112(4):217-21.

PMID:
14987914
28.

Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.

Vayá A, Falcó C, Réganon E, Vila V, Martínez-Sales V, Corella D, Contreras MT, Aznar J.

Thromb Haemost. 2004 Feb;91(2):354-9.

PMID:
14961164
29.
30.

Inflammation, fibrinogen and thrombin generation in patients with previous myocardial infarction.

Réganon E, Vila V, Martínez-Sales V, Vaya A, Aznar J.

Haematologica. 2002 Jul;87(7):740-5; discussion 745.

31.

Relationship between fibrinogen protein and fibrinogen function in postmyocardial infarction patients.

Réganon E, Martínez-Sales V, Vila V, Vayá A, Martinez M, Palencia MA, Aznar J.

Thromb Res. 2001 Dec 15;104(6):413-9.

PMID:
11755951
32.

Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes.

Vila V, Martínez-Sales V, Réganon E, Peris E, Perez F, Ruano M, Aznar J.

Haematologica. 2001 Jul;86(7):729-34.

33.

Elevated high molecular weight fibrinogen in plasma is predictive of coronary ischemic events after acute myocardial infarction.

Reganon E, Vila V, Ferrando F, Martínez-Sales V, Fayos L, Ruano M, Aznar J.

Thromb Haemost. 1999 Nov;82(5):1403-5.

PMID:
10595627
34.

Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study.

Martínez-Sales V, Vila V, Réganon E, Goberna MA, Ferrando F, Palencia MA, Aznar J.

Haemostasis. 1998 Nov-Dec;28(6):301-6.

PMID:
10461012
35.

Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone.

Réganon E, Ferrando F, Vila V, Villa P, Martínez-Sales V, Fayos L, Ruano M, Aznar J.

Haemostasis. 1998 Mar-Apr;28(2):99-105.

PMID:
10087435
36.

The effect of thrombin on the dynamic exchange between intraplatelet and extraplatelet fibrinogen.

Vila V, Martínez-Sales V, Réganon E, Aznar J.

Br J Haematol. 1997 Dec;99(3):548-54.

PMID:
9401064
37.

Fibrinopeptide A release from intraplatelet fibrinogen is related to thrombin platelet activation.

Vila V, Martinez-Sales V, Réganon E, Aznar J.

Thromb Res. 1997 May 1;86(3):263-9. No abstract available.

PMID:
9175247
38.

Unstimulated and thrombin-stimulated platelets binding to immobilized fibrinogen and fibrin on polystyrene supports.

Martínez-Sales V, Vila V, Réganon E, Aznar J.

Haemostasis. 1995 Jul-Aug;25(4):158-65.

PMID:
7557654
39.

Lack of effect of thrombin on fibrin(ogen)-endothelial cell interaction.

Réganon E, Vila V, Martínez-Sales V, Aznar J.

Cytotechnology. 1995 Jun;19(2):143-51. doi: 10.1007/BF00749769.

PMID:
22359014
40.

Prostacyclin generation by rat aortas obtained by different procedures.

Gabaldón M, Martínez-Sales V, Capdevila C, Zúñiga A.

J Pharmacol Toxicol Methods. 1993 Nov;30(3):159-62. No abstract available.

PMID:
8305717
41.

Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment.

Valles J, Santos MT, Aznar J, Marcus AJ, Martinez-Sales V, Portoles M, Broekman MJ, Safier LB.

Blood. 1991 Jul 1;78(1):154-62.

PMID:
1712639
42.

Characteristics of arachidonic acid metabolism of human endothelial cells in culture.

Martinez-Sales V, Gomez-Lechón MJ, Gilabert J.

Cytotechnology. 1990 Jan;3(1):21-9.

PMID:
1367459
43.

Arachidonate incorporation into rat aorta lipid fractions and eicosanoid formation. Effect of prolonged prostacyclin production.

Martinez-Sales V, Santos MT, Vallés J, Aznar J.

Prostaglandins Leukot Essent Fatty Acids. 1989 Jan;35(1):1-8.

PMID:
2494674
44.

The effect of EDTA on the production of prostacyclin by rat aorta.

Vallés J, Martínez-Sales V, Aznar J, Santos MT.

Thromb Res. 1986 Aug 15;43(4):479-83. No abstract available.

PMID:
3094192
45.

Effect of dipyridamole plus pentoxifylline in patients with diffuse cerebrovascular insufficiency.

Yayá R, Aznar J, Vayá A, Villa P, Santos T, Vallés J, Martinez-Sales V.

Thromb Haemost. 1985 Dec 17;54(4):896. No abstract available.

PMID:
3911484
46.
47.

Prostacyclin production by rat aorta "in vitro" is increased by the combined action of dipyridamole plus pentoxifylline.

Santos MT, Martinez-Sales V, Vallés J, Aznar J, Yaya R, Vayá A, Villa P.

Prostaglandins. 1985 Jan;29(1):113-22.

PMID:
3919421
48.

Intestinal absorption of cholesterol autoxidation products in the rat.

Fornas E, Martínez-Sales V, Camañas A, Báguena J.

Arch Farmacol Toxicol. 1984 Dec;10(3):175-82. No abstract available.

PMID:
6532324
49.

Dysfunctional plasminogen in full term newborn--study of active site of plasmin.

Benavent A, Estellés A, Aznar J, Martinez-Sales V, Gilabert J, Fornas E.

Thromb Haemost. 1984 Feb 28;51(1):67-70.

PMID:
6232730
50.

Nonhistone protein changes during the diethylnitrosamine-induced carcinogenesis of rat liver.

Martinez-Sales V, Gabaldon M, Baguena J.

Cancer Res. 1981 Mar;41(3):1187-92.

Supplemental Content

Loading ...
Support Center